semaglutide gastroparesis class action in dallas gastrointestinal obstruction bowel Ozempic Lawsuit: June 2026 Blindness and Claims dallas semaglutide digestive blockage law – primarystack mg:5mg Medicare obesity drug GLP-1

semaglutide gastroparesis class action in dallas gastrointestinal obstruction bowel Ozempic Lawsuit: June 2026 Blindness and Claims dallas semaglutide digestive blockage law – primarystack mg:5mg Medicare obesity drug GLP-1

Medicare obesity drug GLP-1 coverage starting July 1

Administrative unit: the entity itself or individual(s) at an organization/institution/company that provides oversight and/or registers and/or reports results information on ClinicalTrials.gov

primarystack

mg:5mg

These weight loss medications, also known as GLP-1 medications, work by influencing hormones to reduce appetite and slow down digestion